Abstract
Background
The use of stimulant medications for treatment of ADHD has raised concern as to whether they adversely impact linear growth. Previous studies have indicated that stimulant medications may suppress growth for a short period after treatment initiation; however, more information is needed to evaluate the long-term effects on final adult stature. This mini review aims to evaluate the effect of stimulant medications on final adult height in children with ADHD.
Contents
We performed a literature review across PubMed/MEDLINE database. Only articles that included data on final adult height or near final adult height (age≥16 or 17 years) were included.
Summary
Early studies investigating the long-term impacts of stimulant medications observed growth suppression during the active treatment period, but when comparing final adult height, there was no difference between the control and ADHD groups. A recent larger comprehensive study (Multimodal Treatment of ADHD study) has suggested that the long-term use of significant doses of stimulants during childhood may compromise final adult height to a clinically significant degree when comparing adult height across three long-term patterns of stimulant treatment (Consistent, Intermittent, Negligible). The consistent use subgroup was significantly shorter than other subgroups.
Outlook
For children with ADHD, a significant long-term dose of stimulant treatment should be used with caution to avoid diminishing adult height potential. Pediatric endocrinologists should consider chronic use of stimulants as a factor contributing to reduced adult height.
-
Research funding: The research was funded by NIH intramural research grant.
-
Author contributions: NMW and EZ searched, selected, and reviewed relevant articles and wrote the manuscript with critical contents in the papers. YHJ supervised the entire review process, provided guidance, revised the manuscript, and added her expert opinion.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. Danielson, ML, Bitsko, RH, Ghandour, RM, Holbrook, JR, Kogan, MD, Blumberg, SJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. Children and adolescents, 2016. J Clin Child Adolesc Psychol 2018;47:199–212. https://doi.org/10.1080/15374416.2017.1417860.Search in Google Scholar PubMed PubMed Central
2. Gaub, M, Carlson, CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997;36:1036–45. https://doi.org/10.1097/00004583-199708000-00023.Search in Google Scholar
3. Ramtekkar, UP, Reiersen, AM, Todorov, AA, Todd, RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry 2010;49:217–28.e1–3. https://doi.org/10.1097/00004583-201003000-00005.Search in Google Scholar
4. Rucklidge, JJ. Gender differences in attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2010;33:357–73. https://doi.org/10.1016/j.psc.2010.01.006.Search in Google Scholar PubMed
5. Wolraich, ML, Hagan, JFJr., Allan, C, Chan, E, Davison, D, Earls, M, et al.. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2019;144:e20192528. https://doi.org/10.1542/peds.2019-2528.Search in Google Scholar PubMed PubMed Central
6. Gould, MS, Walsh, BT, Munfakh, JL, Kleinman, M, Duan, N, Olfson, M, et al.. Sudden death and use of stimulant medications in youths. Am J Psychiatr 2009;166:992–1001. https://doi.org/10.1176/appi.ajp.2009.09040472.Search in Google Scholar PubMed
7. Poulton, A, Cowell, CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health 2003;39:180–5. https://doi.org/10.1046/j.1440-1754.2003.00107.x.Search in Google Scholar PubMed
8. Group, MTAC. National institute of mental health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762–9. https://doi.org/10.1542/peds.113.4.762.Search in Google Scholar PubMed
9. Goldfield, GS, Lorello, C, Doucet, E. Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food? Am J Clin Nutr 2007;86:308–15. https://doi.org/10.1093/ajcn/86.2.308.Search in Google Scholar PubMed
10. Han, Y, Xia, G, He, Y, He, Y, Farias, M, Xu, Y, et al.. A hindbrain dopaminergic neural circuit prevents weight gain by reinforcing food satiation. Sci Adv 2021;7:eabf8719. https://doi.org/10.1126/sciadv.abf8719.Search in Google Scholar PubMed
11. Faraone, SV, Biederman, J, Morley, CP, Spencer, TJ. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:994–1009. https://doi.org/10.1097/chi.obo13e31817eoea7.Search in Google Scholar
12. Goldman, RD. ADHD stimulants and their effect on height in children. Can Fam Physician 2010;56:145–6.Search in Google Scholar
13. Efron, D, Jarman, F, Barker, M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997;100:662–6. https://doi.org/10.1542/peds.100.4.662.Search in Google Scholar
14. Negrao, BL, Viljoen, M. Stimulants and growth in children with attention-deficit/hyperactivity disorder. Med Hypotheses 2011;77:21–8. https://doi.org/10.1016/j.mehy.2011.03.015.Search in Google Scholar
15. Ishibashi, M, Yamaji, T. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. J Clin Invest 1984;73:66–78. https://doi.org/10.1172/jci111208.Search in Google Scholar
16. De Zegher, F, Van Den Berghe, G, Devlieger, H, Eggermont, E, Veldhuis, JD. Dopamine inhibits growth hormone and prolactin secretion in the human newborn. Pediatr Res 1993;34:642–5. https://doi.org/10.1203/00006450-199311000-00016.Search in Google Scholar
17. Toren, P, Silbergeld, A, Eldar, S, Laor, N, Wolmer, L, Koren, S, et al.. Lack of effect of methylphenidate on serum growth hormone (GH), GH-binding protein, and insulin-like growth factor I. Clin Neuropharmacol 1997;20:264–9. https://doi.org/10.1097/00002826-199706000-00011.Search in Google Scholar
18. Bereket, A, Turan, S, Karaman, MG, Haklar, G, Ozbay, F, Yazgan, MY. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Horm Res 2005;63:159–64. https://doi.org/10.1159/000084683.Search in Google Scholar
19. Gumustas, F, Yilmaz, I, Sirin, DY, Gumustas, SA, Batmaz, AG, Isyar, M, et al.. Chondrocyte proliferation, viability and differentiation is declined following administration of methylphenidate utilized for the treatment of attention-deficit/hyperactivity disorder. Hum Exp Toxicol 2017;36:981–92. https://doi.org/10.1177/0960327116678294.Search in Google Scholar
20. Kilgore, BS, Dickinson, LC, Burnett, CR, Lee, J, Schedewie, HK, Elders, MJ. Alterations in cartilage metabolism by neurostimulant drugs. J Pediatr 1979;94:542–5. https://doi.org/10.1016/s0022-3476(79)80007-4.Search in Google Scholar
21. Safer, DJ, Allen, RP, Barr, E. Growth rebound after termination of stimulant drugs. J Pediatr 1975;86:113–6. https://doi.org/10.1016/s0022-3476(75)80720-7.Search in Google Scholar
22. Klein, RG, Landa, B, Mattes, JA, Klein, DF. Methylphenidate and growth in hyperactive children. A controlled withdrawal study. Arch Gen Psychiatr 1988;45:1127–30. https://doi.org/10.1001/archpsyc.1988.01800360075011.Search in Google Scholar PubMed
23. Harstad, EB, Weaver, AL, Katusic, SK, Colligan, RC, Kumar, S, Chan, E, et al.. ADHD, stimulant treatment, and growth: a longitudinal study. Pediatrics 2014;134:e935–44. https://doi.org/10.1542/peds.2014-0428.Search in Google Scholar PubMed PubMed Central
24. Klein, RG, Mannuzza, S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch Gen Psychiatr 1988;45:1131–4. https://doi.org/10.1001/archpsyc.1988.01800360079012.Search in Google Scholar PubMed
25. Kramer, JR, Loney, J, Ponto, LB, Roberts, MA, Grossman, S. Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems. J Am Acad Child Adolesc Psychiatry 2000;39:517–24. https://doi.org/10.1097/00004583-200004000-00022.Search in Google Scholar PubMed
26. Biederman, J, Spencer, TJ, Monuteaux, MC, Faraone, SV. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr 2010;157:635–40.e1. https://doi.org/10.1016/j.jpeds.2010.04.025.Search in Google Scholar PubMed PubMed Central
27. Peyre, H, Hoertel, N, Cortese, S, Acquaviva, E, Limosin, F, Delorme, R. Long-term effects of ADHD medication on adult height: results from the NESARC. J Clin Psychiatr 2013;74:1123–4. https://doi.org/10.4088/jcp.13l08580.Search in Google Scholar PubMed
28. Swanson, JM, Arnold, LE, Molina, BSG, Sibley, MH, Hechtman, LT, Hinshaw, SP, et al.. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry 2017;58:663–78. https://doi.org/10.1111/jcpp.12684.Search in Google Scholar PubMed PubMed Central
29. Greenhill, LL, Swanson, JM, Hechtman, L, Waxmonsky, J, Arnold, LE, Molina, BSG, et al.. Trajectories of growth associated with long-term stimulant medication in the multimodal treatment study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2020;59:978–89. https://doi.org/10.1016/j.jaac.2019.06.019.Search in Google Scholar PubMed PubMed Central
© 2022 Walter de Gruyter GmbH, Berlin/Boston
